HIV, 'an evolving species'. Roles of cellular activation and co-infections (Q40584444)

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

The evolutionary rate of nonpathogenic simian immunodeficiency virus (SIVagm) is in agreement with a rapid and continuous replication in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Simian immunodeficiency virus replicates to high levels in naturally infected African green monkeys without inducing immunologic or neurologic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Pol gene quasispecies of human immunodeficiency virus: mutations associated with drug resistance in virus from patients undergoing no drug therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Viral dynamics in human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

In vivo estimates of division and death rates of human T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Characterization of viral dynamics in human immunodeficiency virus type 1-infected patients treated with combination antiretroviral therapy: relationships to host factors, cellular restoration, and virologic end points

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Quantitative image analysis of HIV-1 infection in lymphoid tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

T-cell antigen receptor V beta subsets are not preferentially deleted in AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Evidence for rapid disappearance of initially expanded HIV-specific CD8+ T cell clones during primary HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Gag-specific cytotoxic responses to HIV type 1 are associated with a decreased risk of progression to AIDS-related complex or AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Kinetics of immune functions and virus replication during HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Longitudinal analysis of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte responses: a predominant gag-specific response is associated with nonprogressive infection

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Antigenic oscillations and shifting immunodominance in HIV-1 infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

The evolutionary dynamics of HIV-1 quasispecies and the development of immunodeficiency disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Extensive variation of human immunodeficiency virus type-1 in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Genomic diversity of human T-lymphotropic virus type III (HTLV-III).

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Viral burden in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Common epitope in human immunodeficiency virus (HIV) I-GP41 and HLA class II elicits immunosuppressive autoantibodies capable of contributing to immune dysfunction in HIV I-infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

HLA mimicry by HIV-1 gp120 in the pathogenesis of AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Human immunodeficiency virus type 1 gp120 C5 region mimics the HLA class I alpha 1 peptide-binding domain.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Cross-reactive response to human immunodeficiency virus type 1 (HIV-1) gp120 and HLA class I heavy chains induced by receipt of HIV-1-derived envelope vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Human antibodies to immunodominant C5 region of HIV-1 gp120 cross-react with HLA class I on activated cells

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

HIV envelope protein is recognized as an alloantigen by human DR-specific alloreactive T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Molecular mimicry of an HLA-DR53 epitope by viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Autoimmune response in AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Does the HIV Nef protein mimic the MHC?

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Molecular mimicry in the MHC: hidden clues to autoimmunity?

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

HIV and HLA similarity

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Molecular mimicry in the pathogenesis of AIDS: the HIV/MHC/mycoplasma triangle

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Enhanced HIV infectivity and changes in GP120 conformation associated with viral incorporation of human leucocyte antigen class I molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Long-term symptomless HIV-1 infection in recipients of blood products from a single donor

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Normal immune function and inability to isolate virus in culture in an individual with long-term human immunodeficiency virus type 1 infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposure

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

How many HIV-infected individuals may be defined as long-term nonprogressors? A report from the Italian Seroconversion Study. Italian Seroconversion Study Group (ISS)

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. A preliminary study

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Failure of T-cell homeostasis preceding AIDS in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

CD4+ T-cell depletion in HIV infection: Are we closer to understanding the cause?

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

T-cell homeostasis in HIV infection is neither failing nor blind: modified cell counts reflect an adaptive response of the host

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Rates of evolution of the retroviral oncogene of Moloney murine sarcoma virus and of its cellular homologues

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Plasma viremia in human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Quantitation of human immunodeficiency virus type 1 in the blood of infected persons

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Detection of lymphocytes expressing human T-lymphotropic virus type III in lymph nodes and peripheral blood from infected individuals by in situ hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Viral variability and serum antibody response in a laboratory worker infected with HIV type 1 (HTLV type IIIB).

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Antibodies to Mycoplasma fermentans in HIV-positive heterosexual patients: Seroprevalence and association with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

High frequency of antibodies to Mycoplasma penetrans in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

A longitudinal study of seroreactivity against Mycoplasma penetrans in HIV-infected homosexual men: association with disease progression.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Mycoplasma can enhance HIV replication in vitro: a possible cofactor responsible for the progression of AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Enhancement of HIV-1 cytocidal effects in CD4+ lymphocytes by the AIDS-associated mycoplasma

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Mycoplasmas stimulate replication of human immunodeficiency virus type 1 through selective activation of CD4+ T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Mycoplasmas regulate HIV-LTR-dependent gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Mycoplasmas and HIV infection: from epidemiology to their interaction with immune cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Disseminated Mycoplasma fermentans in AIDS patients: several case reports

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Mycoplasma fermentans in individuals seropositive and seronegative for HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Induction of CD4 and susceptibility to HIV-1 infection in human CD8+ T lymphocytes by human herpesvirus 6

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Productive dual infection of human CD4+ T lymphocytes by HIV-1 and HHV-6.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

The Epstein-Barr virus DNA polymerase transactivates the human immunodeficiency virus type 1 5' long terminal repeat

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Mannoproteins of Cryptococcus neoformans induce proliferative response in human peripheral blood mononuclear cells (PBMC) and enhance HIV-1 replication

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Effect of immune activation induced by Cryptosporidium parvum whole antigen on in vitro human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Alternative mechanisms for activation of human immunodeficiency virus enhancer in T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Reduced T-cell receptor CD3zeta-chain protein and sustained CD3epsilon expression at the site of mycobacterial infection

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Increased Replication of HIV-1 at Sites of Mycobacterium tuberculosis Infection: Potential Mechanisms of Viral Activation

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Missing infections in AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

The effect of Plasmodium falciparum malaria on HIV-1 RNA blood plasma concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Selected P. falciparum specific immune responses are maintained in AIDS adults in Burkina Faso

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Persistent diarrhoea in Zairian AIDS patients: an endoscopic and histological study

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Discordant cellular and humoral immune responses to cytomegalovirus infection in healthy blood donors: existence of a Th1-type dominant response.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Declining levels of rescued lymphoproliferative response to human cytomegalovirus (HCMV) in AIDS patients with or without HCMV disease following long-term HAART

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Sustained cytomegalovirus-specific CD4+ T cell response associated with prevention of recurrence of cytomegalovirus retinitis without secondary prophylaxis after highly active antiretroviral therapy in patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Molecular correlates in AIDS patients following antiretroviral therapy: diversified T-cell receptor repertoires and in vivo control of cytomegalovirus replication.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Loss of cytomegalovirus-specific CD4+ T cell responses in human immunodeficiency virus type 1-infected patients with high CD4+ T cell counts and recurrent retinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy maintain activated CD8+ T cell subsets as a strong adaptive immune response to cytomegalovirus.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

CD8 T cells specific for human immunodeficiency virus, Epstein-Barr virus, and cytomegalovirus lack molecules for homing to lymphoid sites of infection

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Skewed maturation of memory HIV-specific CD8 T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

[Strongyloides stercoralis in T-cell leukemia/lymphoma in adults and acquired immunodeficiency syndrome].

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Cellular responses in human strongyloidiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Peripheral lymphocyte subsets and their responsiveness in human strongyloidiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Involvement of IL-2/IL-2R system activation by parasite antigen in polyclonal expansion of CD4(+)25(+) HTLV-1-infected T-cells in human carriers of both HTLV-1 and S. stercoralis

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Progression to AIDS in homosexual men co-infected with HIV and HTLV-I in Trinidad

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Coinfection with human T-cell lymphotropic virus type I and HIV in Brazil. Impact on markers of HIV disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

An international collaborative study of the effects of coinfection with human T-lymphotropic virus type II on human immunodeficiency virus type 1 disease progression in injection drug users

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Activation of Lymphocytes by Varicella-Zoster Virus (VZV): Expression of Interleukin-2 Receptors on Lymphocytes Cultured with VZV Antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Varicella immunity and clinical disease in HIV-infected adults

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Zoster in patients infected with HIV: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

The Th1-Th2 hypothesis of HIV infection: new insights

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Ability of HIV to promote a TH1 to TH0 shift and to replicate preferentially in TH2 and TH0 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Lack of evidence for the dichotomy of TH1 and TH2 predominance in HIV-infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

HIV infection alters the production of both type 1 and 2 cytokines but does not induce a polarized type 1 or 2 state

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

HIV induces modulation of functionally important cellular antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

CD4+CD7-lymphocyte subset is expanded in HIV-infected patients with low CD4 cell count rescue during highly active antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

AIDS pathogenesis: a dynamic interaction between HIV and the immune system

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Preferential infection of CD4+ memory T cells by human immunodeficiency virus type 1: evidence for a role in the selective T-cell functional defects observed in infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Altered lymphocyte antigen expressions in HIV infection: a study by quantitative flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Peripheral T-lymphocyte activation by human T-cell leukemia virus type I interferes with the CD2 but not with the CD3/TCR pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

CD31 (PECAM-1) is a differentiation antigen lost during human CD4 T-cell maturation into Th1 or Th2 effector cells

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

High serum level of the soluble form of CD30 molecule in the early phase of HIV-1 infection as an independent predictor of progression to AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

CD30 expression by CD8+ T cells producing type 2 helper cytokines. Evidence for large numbers of CD8+CD30+ T cell clones in human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Viral load and CD69 molecule expression on freshly isolated and cultured mitogen-stimulated lymphocytes of children with perinatal HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Expression of CD69 on T-cells from HIV-1-infected children and adolescents increases with increasing viral load

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Extracellular HIV type 1 Tat protein induces CD69 expression through NF-kappaB activation: possible correlation with cell surface Tat-binding proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Cell surface down-modulation of CD4 after infection by HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Nef 27, but not the Nef 25 isoform of human immunodeficiency virus-type 1 pNL4.3 down-regulates surface CD4 and IL-2R expression in peripheral blood mononuclear cells and transformed T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

The human immunodeficiency virus type 1 Vpu protein specifically binds to the cytoplasmic domain of CD4: implications for the mechanism of degradation

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Differential activities of the human immunodeficiency virus type 1-encoded Vpu protein are regulated by phosphorylation and occur in different cellular compartments

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

The role of Nef in the replication cycle of the human and simian immunodeficiency viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Expression of the type 1 human immunodeficiency virus Nef protein in T cells prevents antigen receptor-mediated induction of interleukin 2 mRNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

HIV-1-infected T cells show a selective signaling defect after perturbation of CD3/antigen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Human immunodeficiency virus-specific circulating CD8 T lymphocytes have down-modulated CD3zeta and CD28, key signaling molecules for T-cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Unraveling the function of HIV type 1 Nef.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

An examination of signs of disease progression in survivors of the Sydney Blood Bank Cohort (SBBC).

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Markers of immune cell activation and disease progression. Cell activation in HIV disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

T cell activation and disease severity in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Efficacy of low-dose intermittent subcutaneous interleukin (IL)--2 in antiviral drug--experienced human immunodeficiency virus--infected persons with detectable virus load: a controlled study of 3 il-2 regimens with antiviral drug therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

A risk-benefit assessment of interleukin-2 as an adjunct to antiviral therapy in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

In vitro production of type 1 and type 2 cytokines by peripheral blood mononuclear cells from high-risk HIV-negative intravenous drug users

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Human CD4 helper T cell activation: functional involvement of two distinct collagen receptors, 1F7 and VLA integrin family

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Lymphocyte activation in HIV-1 infection. II. Functional defects of CD28- T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

The CD28/HLA-DR expressions on CD4+T but not CD8+T cells are significant predictors for progression to AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

The effects of CD3, CD4 and CD28 signaling on lymphocytes during human immunodeficiency virus‐1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Dysregulation of B7.2 (CD86) expression on monocytes of HIV-infected individuals is associated with altered production of IL-2

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

CTLA-4 upregulation during HIV infection: association with anergy and possible target for therapeutic intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Nef triggers a transcriptional program in T cells imitating single-signal T cell activation and inducing HIV virulence mediators

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

The role of CD80 and CD86 in enhancing CD8(+) cell suppression of HIV replication

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Impairment of B-lymphocyte differentiation induced by dual triggering of the B-cell antigen receptor and CD40 in advanced HIV-1-disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Role of CD40 ligand signaling in defective type 1 cytokine response in human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

T-cell subset alterations and lymphocyte responsiveness to mitogens and antigen during severe primary infection with HIV: a case series of seven consecutive HIV seroconverters

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Cytotoxic T lymphocytes against HIV

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Inhibition of human immunodeficiency virus replication in acutely infected CD4+ cells by CD8+ cells involves a noncytotoxic mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Biologic features of HIV-1 that correlate with virulence in the host

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

CD8+ cell anti-HIV activity: nonlytic suppression of virus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

An activated CD8+ T cell phenotype correlates with anti-HIV activity and asymptomatic clinical status

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

CD8 naive T cell counts decrease progressively in HIV-infected adults

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Oligoclonal expansions of CD8(+) T cells in chronic HIV infection are antigen specific.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

HIV type 1-specific IgG2 antibodies: markers of helper T cell type 1 response and prognostic marker of long-term nonprogression

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

The immunology of HIV-infected long-term non-progressors--a current view.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

High frequency of Gag- and envelope-specific cytotoxic T lymphocyte precursors in children with vertically acquired human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

High-purity factor concentrates in prevention of AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Three-year randomised study of high-purity or intermediate-purity factor VIII concentrates in symptom-free HIV-seropositive haemophiliacs: effects on immune status

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

The effect of monoclonal or ion-exchange purified factor VIII concentrate on HIV disease progression: a prospective cohort comparison

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Effect of high- versus intermediate-purity blood coagulation factor concentrates on HIV-1 replication

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Risks of immunodeficiency, AIDS, and death related to purity of factor VIII concentrate. Multicenter Hemophilia Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Human immunodeficiency virus type 1-specific cytotoxic T lymphocyte activity is inversely correlated with HIV type 1 viral load in HIV type 1-infected long-term survivors

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

HIV-1 suppression by early treatment with hydroxyurea, didanosine, and a protease inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Immune Restoration by Combination of a Cytostatic Drug (Hydroxyurea) and Anti-HIV Drugs (Didanosine and Indinavir)

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: results of AIDS Clinical Trials Group Protocol 315.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Tumour necrosis factor (TNF) and TNF-related molecules in HIV-1+ individuals: relationship with in vitro Th1/Th2-type response

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

CD30, Th2 cytokines and HIV infection: a complex and fascinating link

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Role for CD30 in HIV expression.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Activation of HIV expression by CD30 triggering in CD4+ T cells from HIV-infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Increased numbers of primed activated CD8+CD38+CD45RO+ T cells predict the decline of CD4+ T cells in HIV-1-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Selective increase of activation antigens HLA-DR and CD38 on CD4+ CD45RO+ T lymphocytes during HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Regulation of class II expression in monocytic cells after HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

The significance of activation markers on CD8 lymphocytes in human immunodeficiency syndrome: staging and prognostic value

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

CD8+ lymphocyte activation at human immunodeficiency virus type 1 seroconversion: development of HLA-DR+ CD38- CD8+ cells is associated with subsequent stable CD4+ cell levels. The Multicenter AIDS Cohort Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Characterization of T cell subsets involved in the production of IFN-gamma in asymptomatic HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Delayed virus-specific CD8+ cytotoxic T lymphocyte activity in an HIV-infected individual with high CD4+ cell counts: correlations with various parameters of disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Major histocompatibility complex class II DR alleles DRB1*1501 and those encoding HLA-DR13 are preferentially associated with a diminution in maternally transmitted human immunodeficiency virus 1 infection in different ethnic groups: determination b

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Cell cycling in HIV infection: analysis of in vivo activated lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Different meaning of CD38 molecule expression on CD4+ and CD8+ cells of children perinatally infected with human immunodeficiency virus type 1 infection surviving longer than five years

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Changes in blood CD8+ lymphocyte activation status and plasma HIV RNA levels during antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Leukocyte function-associated antigen-1 expression on peripheral blood mononuclear cell subsets in HIV-1 seropositive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Disproportionate expansion of a minor T cell subset in patients with lymphadenopathy syndrome and acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Abnormality of Leu 2+7+ cells in acquired immune deficiency syndrome (AIDS), AIDS-related complex, and asymptomatic homosexuals.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Expansion of CD57 and CD62L-CD45RA+ CD8 T lymphocytes correlates with reduced viral plasma RNA after primary HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

CD8hi+CD57+ T lymphocytes are enriched in antigen-specific T cells capable of down-modulating cytotoxic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Oligoclonal expansions in the CD8(+)CD28(-) T cells largely explain the shorter telomeres detected in this subset: analysis by flow FISH

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Expansion of T cells negative for CD28 expression in HIV infection. Relation to activation markers and cell adhesion molecules, and correlation with prognostic markers

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Persistent HIV-1-specific cellular responses despite prolonged therapeutic viral suppression

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Highly active antiretroviral therapy responders exhibit a phenotypic lymphocyte pattern comparable to that of long-term nonprogressors.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Expansions of peripheral blood CD8 T-lymphocyte subpopulations and an association with cytomegalovirus seropositivity in the elderly: the Swedish NONA immune study

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Plasma levels of soluble CD27: a simple marker to monitor immune activation during potent antiretroviral therapy in HIV-1-infected subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Downregulation of HLA class I antigens in HIV-1-infected cells

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Mechanism of MHC class I downregulation in HIV infected cells

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

A1, Cw7, B8, DR3 HLA antigen combination associated with rapid decline of T-helper lymphocytes in HIV-1 infection. A report from the Multicenter AIDS Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

HLA haplotype A1 B8 DR3 as a risk factor for HIV-related disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Association of HLA types A1-B8-DR3 and B27 with rapid and slow progression of HIV disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Major expansion of CD8+ T cells with a predominant V beta usage during the primary immune response to HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

HLA-Associated susceptibility to AIDS: HLA B35 is a major risk factor for Italian HIV-infected intravenous drug addicts

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Progression to AIDS in French haemophiliacs: association with HLA-B35.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

HLA and AIDS: a cautionary tale

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Superantigens and Endogenous Retroviruses: A Confluence of Puzzles

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Superantigen implicated in dependence of HIV-1 replication in T cells on TCR V beta expression

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

A strategy for prophylactic vaccination against HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Enhancing of anti-viral activity against HIV-1 by stimulation of CD8+ T cells with thymic peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Long-term observations of human immunodeficiency virus-infected chimpanzees

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

HIV infection of CD8 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

The replication of human immunodeficiency virus type 1 in macrophages is enhanced after phagocytosis of apoptotic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Emergence and genetic evolution of HIV-1 variants with mutations conferring resistance to multiple reverse transcriptase and protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Interactions between drug resistance mutations in human immunodeficiency virus type 1 reverse transcriptase

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

1 reference

7 January 2021

Population structure of pathogens: the role of immune selection

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Changes in human immunodeficiency virus type 1 populations after treatment interruption in patients failing antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Origins and evolution of AIDS viruses: estimating the time-scale

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

One explanation of Nef gene behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Life on the edge of catastrophe

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021

Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2803%2900147-6

7 January 2021